Seqens Seqens

X

Digital content for F-star Therapeutics

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
F-star Therapeutics
unitedkingdom_new Flag
Country
Country
United Kingdom
Address
Address
Eddeva B920 Babraham Research Campus Cambridge, CB22 3AT
Telephone
Telephone
+44-1223-497400
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://endpts.com/f-star-bags-third-takeda-tie-up-in-a-year-with-multi-specific-antibodies-for-cancer/

Kyle LaHucik ENDPTS
06 Jul 2023

https://www.businesswire.com/news/home/20230308005755/en

BUSINESSWIRE
08 Mar 2023

https://www.globenewswire.com/news-release/2023/03/07/2622160/0/en/F-star-Therapeutics-Announces-CFIUS-Clearance-for-Proposed-Acquisition-by-invoX-Pharma.html

GLOBENEWSWIRE
07 Mar 2023

https://endpts.com/f-stars-sale-to-chinese-buyer-cleared-by-cfius-following-months-of-holdup/

Amber Tong ENDPTS
07 Mar 2023

https://www.marketwatch.com/story/f-star-therapeutics-stock-jumps-on-extension-to-invox-pharma-merger-deadline-271675271722?mod=markets

MARKETWATCH
01 Feb 2023

https://endpts.com/f-star-invox-pharma-sale-cfius-national-security/

Amber Tong ENDPTS
27 Jan 2023

https://www.globenewswire.com/news-release/2023/01/26/2596450/0/en/invoX-Pharma-and-F-star-Therapeutics-issue-Joint-Statement.html

GLOBENEWSWIRE
26 Jan 2023

https://endpts.com/us-blocks-f-stars-takeover-citing-national-security-risks/

Drew Armstrong ENDPTS
30 Dec 2022

https://pulse2.com/why-the-f-star-therapeutics-fstx-stock-plummeted-40-38/

PULSE2
29 Dec 2022

https://endpts.com/in-yet-another-delay-for-the-f-star-buyout-cfius-extends-review-of-national-security-risks/

John Carroll ENDPTS
20 Dec 2022
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY